Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer

NCT01020864 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Cetuximab
DRUG: Carboplatin
DRUG: Vinorelbine

Sponsor

Per Pfeiffer

Collaborators

[object Object]